PH31591A - Aqueous 6- (3-(3, 4-dimethoxybenzyl)-amino -2- hydroxypropoxy carbostyril compositions. - Google Patents
Aqueous 6- (3-(3, 4-dimethoxybenzyl)-amino -2- hydroxypropoxy carbostyril compositions.Info
- Publication number
- PH31591A PH31591A PH48673A PH48673A PH31591A PH 31591 A PH31591 A PH 31591A PH 48673 A PH48673 A PH 48673A PH 48673 A PH48673 A PH 48673A PH 31591 A PH31591 A PH 31591A
- Authority
- PH
- Philippines
- Prior art keywords
- pct
- carbostyril
- hydroxypropoxy
- dimethoxybenzyl
- amino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18597393 | 1993-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH31591A true PH31591A (en) | 1998-11-03 |
Family
ID=16180120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH48673A PH31591A (en) | 1993-07-28 | 1994-07-21 | Aqueous 6- (3-(3, 4-dimethoxybenzyl)-amino -2- hydroxypropoxy carbostyril compositions. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5686440A (et) |
| EP (1) | EP0662833B1 (et) |
| KR (1) | KR0178308B1 (et) |
| CN (1) | CN1060041C (et) |
| AT (1) | ATE207358T1 (et) |
| AU (1) | AU669451B2 (et) |
| CA (1) | CA2144729A1 (et) |
| DE (1) | DE69428771T2 (et) |
| DK (1) | DK0662833T3 (et) |
| ES (1) | ES2166375T3 (et) |
| GR (1) | GR3037007T3 (et) |
| PH (1) | PH31591A (et) |
| PT (1) | PT662833E (et) |
| TW (1) | TW254855B (et) |
| WO (1) | WO1995003802A1 (et) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY129350A (en) * | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4164570A (en) * | 1973-09-24 | 1979-08-14 | David Clough | Stabilized aqueous catecholamine solutions |
| DE3333719A1 (de) * | 1983-09-17 | 1985-04-04 | Bayer Ag | Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren |
| EP0355583B1 (en) * | 1988-08-10 | 1995-01-25 | Otsuka Pharmaceutical Co., Ltd. | Cardiotonics |
-
1994
- 1994-07-19 TW TW083106575A patent/TW254855B/zh active
- 1994-07-21 PH PH48673A patent/PH31591A/en unknown
- 1994-07-25 EP EP94921811A patent/EP0662833B1/en not_active Expired - Lifetime
- 1994-07-25 AT AT94921811T patent/ATE207358T1/de not_active IP Right Cessation
- 1994-07-25 DK DK94921811T patent/DK0662833T3/da active
- 1994-07-25 US US08/407,027 patent/US5686440A/en not_active Expired - Fee Related
- 1994-07-25 KR KR1019950701033A patent/KR0178308B1/ko not_active IP Right Cessation
- 1994-07-25 WO PCT/JP1994/001222 patent/WO1995003802A1/en active IP Right Grant
- 1994-07-25 AU AU72378/94A patent/AU669451B2/en not_active Ceased
- 1994-07-25 ES ES94921811T patent/ES2166375T3/es not_active Expired - Lifetime
- 1994-07-25 CA CA002144729A patent/CA2144729A1/en not_active Abandoned
- 1994-07-25 DE DE69428771T patent/DE69428771T2/de not_active Expired - Fee Related
- 1994-07-25 PT PT94921811T patent/PT662833E/pt unknown
- 1994-07-25 CN CN94190548A patent/CN1060041C/zh not_active Expired - Fee Related
-
2001
- 2001-10-25 GR GR20010401665T patent/GR3037007T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0662833A1 (en) | 1995-07-19 |
| TW254855B (et) | 1995-08-21 |
| EP0662833B1 (en) | 2001-10-24 |
| ES2166375T3 (es) | 2002-04-16 |
| CN1113074A (zh) | 1995-12-06 |
| CN1060041C (zh) | 2001-01-03 |
| US5686440A (en) | 1997-11-11 |
| CA2144729A1 (en) | 1995-02-09 |
| KR950703342A (ko) | 1995-09-20 |
| DK0662833T3 (da) | 2001-12-03 |
| AU669451B2 (en) | 1996-06-06 |
| DE69428771T2 (de) | 2002-05-08 |
| DE69428771D1 (de) | 2001-11-29 |
| GR3037007T3 (en) | 2002-01-31 |
| AU7237894A (en) | 1995-02-28 |
| ATE207358T1 (de) | 2001-11-15 |
| KR0178308B1 (ko) | 1999-03-20 |
| PT662833E (pt) | 2002-02-28 |
| WO1995003802A1 (en) | 1995-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3035621T3 (en) | New pyrimidone derivatives with antifungal activity | |
| PL324890A1 (en) | Halogenbenzimidazoles and their application as microbicides | |
| MY122621A (en) | Compositions containing a high percent saturation concentration of antibacterial agent | |
| DE69408666D1 (de) | Risperidon pamoate | |
| TR200102839T2 (tr) | LH agonistleri olarak faydalı bisiklik heteroaromatik bileşikler. | |
| IL144026A0 (en) | Phenylphenanthridine derivatives and pharmaceutical compostions containing the same | |
| ES2196072T3 (es) | Empleo de compuestos heterociclicos como ligandos de dopamina-d3. | |
| PL338452A1 (en) | Novel substituted 6-phenylphenatridines | |
| GR3026187T3 (en) | Herbicidal heterocyclic-substituted pyridines | |
| BG106366A (en) | Moxifloxacin formulation containing common salt | |
| ATE191495T1 (de) | Schmiermittelzusammensetzungen | |
| BR0215032A (pt) | Composição herbicidamente ativa, método para controlar vegetação indesejável, e, uso de composições | |
| MXPA03000606A (es) | Derivados de benzofurano y su uso como agentes antibacterianos. | |
| PL350554A1 (en) | Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy | |
| PH31591A (en) | Aqueous 6- (3-(3, 4-dimethoxybenzyl)-amino -2- hydroxypropoxy carbostyril compositions. | |
| AR030919A1 (es) | Feniluracilos substituidos, composiciones herbicidas, y empleo de dichos compuestos para la lucha contra las plantas indeseables | |
| AU7251287A (en) | Pyridine compounds | |
| IL127321A0 (en) | N-sulphonylimidazoles and the use thereof as microbicides | |
| WO2001032650A3 (en) | Alkaline salts of n-(6-alkyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinesulfone)-n'-isonicotinoylhydrazide, possess for their preparation, and pharmaceutical composition based on these salts | |
| EP0982031A3 (en) | Antifungal compositions comprising voriconazole and trovafloxacin or prodrugs thereof |